Botulinum Toxin Type A (AGN-151607) for the Prevention of Post-operative Atrial Fibrillation in Adult Participants Undergoing Open-chest Cardiac Surgery (NOVA)
Clinical trial NCT03779841 · COMPLETED
Trial details
- NCT number
- NCT03779841
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-01
- Primary completion
- 2022-03-24
- Enrollment
- 323
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.